(Q35276631)

7 August 2017

1 reference

title

The pathogenesis of AIDS lymphomas: a foundation for addressing the challenges of therapy and prevention (English)

1 reference

7 August 2017

J. E. Karp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1362682

18 September 2022

S. Broder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1362682

18 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1362682

18 September 2022

publication date

1 October 1992

1 reference

7 August 2017

1 reference

7 August 2017

volume

8

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

167-188

1 reference

An idiotypic network model of AIDS immunopathogenesis

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Human immunodeficiency virus induction of malignant transformation in human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

AIDS-associated non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Value of necropsy in acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

NIH conference. Antiretroviral therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Zidovudine and the natural history of the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

CD4 Count and the Risk for Death in Patients Infected with HIV Receiving Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

HIV-associated Hodgkin disease: a clinical study of 18 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

NIH conference. Molecular genetic analysis of human lymphoid neoplasms. Immunoglobulin genes and the c-myc oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Modulation of cellular gene expression in B lymphoma cells followingin vitro infection by Epstein-Barr virus (EBV)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Central-nervous-system lymphoma related to Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Role of human immunodeficiency virus type 1 and other viruses in malignancies associated with acquired immunodeficiency disease syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Origins of human cancer revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Functional inactivation of genes by dominant negative mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Tumor suppressor genes: new prospects for cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell l

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Increased radiosensitivity and the basic defect in ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Drug-induced DNA damage and tumor chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasis lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Activation of human immunodeficiency virus type 1 by DNA damage in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Activation of human immunodeficiency virus by ultraviolet radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

DNA repair in the c-myc proto-oncogene locus: possible involvement in susceptibility or resistance to plasmacytoma induction in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Herpesvirus saimiri: Enhancement of Adenovirus-Associated Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Transfer of a functional human immune system to mice with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

Oligonucleotide-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209054903

10.3109/10428199209054903

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference